(Q40694366)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author

Carlos Henrique Serezani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Gerhard Wunderlich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Amanda Richards Franco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Mariana Wajc

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Jenicer K Umada Yokoyama-Yasunaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Monamaris Marques Borges

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Silvia Reni Bortolin Uliana

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

31-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

3755-3763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Characterisation and expression of a stage-regulated gene of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Leishmania: overexpression and comparative structural analysis of the stage-regulated meta 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

The structural genes for three Drosophila glue proteins reside at a single polytene chromosome puff locus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Nucleic acid immunization: concepts and techniques associated with third generation vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

The metacyclic stage-expressed meta-1 gene is conserved between Old and New World Leishmania species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45W antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

Regulation of naive T cell differentiation by varying the potency of TCR signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900354-7

7 January 2021

10.1016/S0264-410X(02)00354-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399206%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference